Algo version: 0.98b
PuraPharm Corp Ltd is listed at the HKSE Exchange
PuraPharm Corp Ltd [1498.HK]
HKSE Sector: Pharmaceuticals Industry:Drug Manufacturers—Specialty & Generic

Is PuraPharm Corp Ltd stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, PuraPharm Corp Ltd pays dividends. Last time was Friday 23rd of June 2017 where the investors holding the stock on Wednesday 31st of May 2017 were paid HKD0.0202 per share. Over the last 2 times between 2016 and 2017, PuraPharm Corp Ltd has paid HKD0.104161 with an average of HKD0.05 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for PuraPharm Corp Ltd 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD1.445, you would have made a loss of HKD-0.745 per share or -51.56%

No, the average daily trading liquidity for PuraPharm Corp Ltd is HKD54 165 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

PuraPharm Corp Ltd has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.13, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for PuraPharm Corp Ltd to be high [0.7 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.